Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Society of Toxicology's 52nd Annual Meeting to be held from Mar. 10-16 in San Antonio

A group of 7,000 scientists working in multiple specialties, from more than 50 countries, will meet March 10-14, 2013 at the Henry B. Gonzalez Convention Center in San Antonio, Texas, to share their latest findings on 60 topical issues of concern to human health and the environment.

7 Feb 2013

Occupational exposure to magnetic fields may moderately increase risk of Alzheimer's, ALS

Occupational exposure to magnetic fields (MF) may be associated with "moderately increased risk" of certain neurodegenerative diseases—including Alzheimer's and amyotrophic lateral sclerosis, reports the February Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

7 Feb 2013

Elan agrees to restructure Tysabri collaboration with Biogen Idec

Elan Corporation, plc today announced that it has agreed to restructure the Tysabri® collaboration with Biogen Idec.

6 Feb 2013

Researchers pinpoint how vitamin D3 and omega-3 may boost immunity to help fight Alzheimer's

A team of academic researchers has pinpointed how vitamin D3 and omega-3 fatty acids may enhance the immune system's ability to clear the brain of amyloid plaques, one of the hallmarks of Alzheimer's disease.

5 Feb 2013

Presenilin-1 gene plays central role in development of neuronal histamine system

Researchers at University of Helsinki, Finland, have shown in a study conducted on zebrafish, that the presenilin-1 (psen1) gene associated with Alzheimer's disease functions as a central regulator for the development of the histamine system. Histamine system is also altered in patients suffering from Alzheimer's disease.

5 Feb 2013

Delirium overlooked in hospital patients

Delirium occurs in about one in five inpatients, but appears to be a low priority with hospital staff, research suggests.

4 Feb 2013

Scientists receive honorary doctorate for research on Alzheimer's disease

On Monday 4 February, Dennis J. Selkoe and five other "brain teasers" will receive an honorary doctorate from the KU Leuven. The promoters for this honorary doctorate - VIB-KU Leuven professors Bart De Strooper and Wim Robberecht - will honor Dennis J. Selkoe for his scientific insights, but also for his relentless search for new medicines to treat Alzheimer's Disease and other conditions that cause severe damage in the brain.

4 Feb 2013

NFL funds WSU research to fix injured brains with new nerve cells

The National Football League thinks enough of the work that its charitable arm has given Krzysztof Czaja (pronounced K-shish-toff Chai-uh), a Washington State University neuroscientist, $100,000 to keep looking.

4 Feb 2013

New survey outlines funding deficiency in brain and eye disease research

BrightFocus Foundation, a nonprofit organization that funds research worldwide to save sight and mind, today released the results of a survey of more than 170 leading biomedical scientists that explores the most significant barriers to progress in ending brain and eye diseases.

2 Feb 2013

Experts contemplate whether Medicare should pay for Alzheimer's test

Also in the news, Astra Zeneca and Bristol-Myers Squibb step up their diabetes-drug partnership.

2 Feb 2013

New drug to prevent early stages of Alzheimer's could enter clinical trials soon

A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.

2 Feb 2013

Medicare expands competitive bidding program

The new prices will kick in July 1 and are expected to save on average 45 percent for products such as walkers, wheelchairs, oxygen equipment and other medical products.

2 Feb 2013

Cerebrolysin: a promising new treatment for dementia

Dementia patients may benefit from a promising new treatment called Cerebrolysin, according to the results of a systematic review published in The Cochrane Library. The authors brought together the most up-to-date evidence on Cerebrolysin as a treatment for vascular dementia.

31 Jan 2013

State roundup: Ga. hospital fee bill nears passage

After a series of friendly questions and statements of support, the fast-tracked legislation on a state hospital provider fee swept through a House committee Tuesday. The House Government Affairs Committee, by a 15-1 vote, approved Senate Bill 24, which would facilitate the renewal of the assessment. The state Senate passed the bill earlier this month. The legislation could reach the House floor Thursday or Friday. If it passes, it then would go to Gov. Nathan Deal for his signature -- an unusually rapid journey into law.

31 Jan 2013

Klotho protein plays important role in the health of myelin

Researchers at Boston University School of Medicine (BUSM) led by Carmela Abraham, PhD, professor of biochemistry, along with Cidi Chen, PhD, and other collaborators, report that the protein Klotho plays an important role in the health of myelin, the insulating material allowing for the rapid communication between nerve cells.

31 Jan 2013